Trumenba Interactions
There are 298 drugs known to interact with Trumenba (meningococcal group B vaccine), along with 2 disease interactions. Of the total drug interactions, 1 is major, 295 are moderate, and 2 are minor.
- View all 298 medications that may interact with Trumenba
- View Trumenba disease interactions (2)
Most frequently checked interactions
View interaction reports for Trumenba (meningococcal group B vaccine) and the medicines listed below.
- Adacel (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Allegra (fexofenadine)
- Arexvy (rsv vaccine pref3, recombinant)
- betamethasone / clotrimazole topical
- bupropion
- Comirnaty (COVID-19 mRNA (Pfizer) vaccine)
- Creon (pancrelipase)
- Engerix-B (hepatitis b adult vaccine)
- Entresto (sacubitril / valsartan)
- eplerenone
- famotidine
- Farxiga (dapagliflozin)
- fexofenadine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- Flublok Quadrivalent (influenza virus vaccine, inactivated)
- Flucelvax Quadrivalent (influenza virus vaccine, inactivated)
- fluticasone
- Lantus SoloStar (insulin glargine)
- lisinopril
- lovastatin
- Low Dose ASA (aspirin)
- magnesium glycinate
- measles virus vaccine / mumps virus vaccine / rubella virus vaccine
- Menactra (meningococcal conjugate vaccine)
- MenQuadfi (meningococcal conjugate vaccine)
- Menveo (meningococcal conjugate vaccine)
- metoprolol
- Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA (Pfizer) vaccine)
- Pneumovax 23 (pneumococcal 23-polyvalent vaccine)
Trumenba disease interactions
There are 2 disease interactions with Trumenba (meningococcal group B vaccine) which include:
Report options
QR code containing a link to this page
More about Trumenba (meningococcal group B vaccine)
- Trumenba consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.